Adoption Momentum For Paradigm4’s UK Biobank Platform

WALTHAM, Mass.–(BUSINESS WIRE)–Two weeks after the launch
announcement
of Paradigm4’s Precision Medicine platform and its
early adopters, Paradigm4 is announcing that another top 15 pharma
company has selected Paradigm4 to exploit the power of the UK Biobank
data.

Paradigm4’s
newly launched REVEAL™ Translational Informatics Platform with its
PheGe™ Browser enables bioinformaticians and scientists to readily work
with the scale and diversity of public and proprietary multi-omics,
behavioral, clinical, health outcomes, and environmental data generated
today. Built on Paradigm4’s scientific data computational engine for
complex data analysis and machine learning, REVEAL™ accelerates
integrative, multi-modal, longitudinal, population-scale data science
exploration and discovery.

“The absolute scale and diversity of the data in the UK Biobank will
drive transformational GWAS/PheWAS research,” said Paradigm4’s CEO
Marilyn Matz. “Our aggressive timelines provide biopharma customers with
best-in-class performance and services to rapidly mine this valuable
data set.”

“The UK Biobank dataset redefines our view of Real World Evidence to
support active clinical development projects where new insights into
cohort selection for recruiting or stratifying patients are very
valuable,” added Zachary Pitluk, Ph.D., V.P. of Life Sciences. “The UK
Biobank data in REVEAL™ is a unique resource for in-silico trial
simulations with its ease of data selection and support for optimizing
machine learning parameters. Enabling our customers with a truly private
analytical environment offers a distinct advantage in a competitive
market like drug development.”

About Paradigm4

Paradigm4,
a scientific information solutions provider, advances scientific and
engineering insights by enabling scientists and data scientists to take
full advantage of the scale, resolution, and diversity of public and
proprietary scientific data to accelerate their research. Leading Life
Sciences, IoT, instrument, and research institutes use Paradigm4’s
REVEAL™ discovery engine for collaborative, reproducible research. The
company was founded by renowned database researcher, Turing Award
laureate MIT Professor Michael
Stonebraker
.

Contacts

Zachary Pitluk, Ph.D., V.P., Life Sciences and Healthcare
zpitluk@paradigm4.com
203-848-0930

Marilyn Matz, CEO
mmatz@paradigm4.com
781-718-3999